Nanjing Shengderui Pharmaceutical Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Nanjing Shengderui Pharmaceutical General Information

Description

Developer of innovative diabetes therapeutics designed to treat metabolic diseases through glucose kinase science and pancreatic islet research. The company develops glucose kinase activators and islet-focused metabolic drug candidates, enabling healthcare providers to offer more effective treatment options for patients with type 2 diabetes and related metabolic disorders.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2nd Floor, Building D-3
  • Number 73 Tanmi Road, Jiangbei New District
  • Nanjing, Jiangsu 210000
  • China
+86 025
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 2nd Floor, Building D-3
  • Number 73 Tanmi Road, Jiangbei New District
  • Nanjing, Jiangsu 210000
  • China
+86 025

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanjing Shengderui Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nanjing Shengderui Pharmaceutical‘s full profile, request access.

Request a free trial

Nanjing Shengderui Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanjing Shengderui Pharmaceutical FAQs

  • When was Nanjing Shengderui Pharmaceutical founded?

    Nanjing Shengderui Pharmaceutical was founded in 2018.

  • Where is Nanjing Shengderui Pharmaceutical headquartered?

    Nanjing Shengderui Pharmaceutical is headquartered in Nanjing, China.

  • What is the size of Nanjing Shengderui Pharmaceutical?

    Nanjing Shengderui Pharmaceutical has 5 total employees.

  • What industry is Nanjing Shengderui Pharmaceutical in?

    Nanjing Shengderui Pharmaceutical’s primary industry is Drug Discovery.

  • Is Nanjing Shengderui Pharmaceutical a private or public company?

    Nanjing Shengderui Pharmaceutical is a Private company.

  • What is the current valuation of Nanjing Shengderui Pharmaceutical?

    The current valuation of Nanjing Shengderui Pharmaceutical is .

  • What is Nanjing Shengderui Pharmaceutical’s current revenue?

    The current revenue for Nanjing Shengderui Pharmaceutical is .

  • When was Nanjing Shengderui Pharmaceutical acquired?

    Nanjing Shengderui Pharmaceutical was acquired on 02-Dec-2022.

  • Who acquired Nanjing Shengderui Pharmaceutical?

    Nanjing Shengderui Pharmaceutical was acquired by Hua Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process